Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Global Markets for Emerging Insulin Drug and Delivery Technologie...
This study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with a focus on insulin pens. The study includes market projections through the end of 2013 and for a five-year period until 2018.
Therapies and Diagnostics for Cervical Cancer
The global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.
Environmental Markets for Biotechnology
U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.
The Global Market for Intravascular Ultrasound Tools and Ancillar...
The global intravascular ultrasound technology (IVUS) products market reached $483.7 million in 2012. The market is expected to reach $702 million in 2017 for a compound annual growth rate (CAGR) of 7.7%.
Global Markets for Rapid Medical Diagnostic Kits
The global market for rapid medical diagnostic kits (MDK) was $16.5 billion in 2011 and nearly $18.4 billion in 2012. This market is expected to reach $24.2 billion in 2017, at an estimated compound annual growth rate (CAGR) of 5.7% from 2012 to 2017.
Ubiquitin Proteasome: Global Markets for Research Tools, Diagnost...
The global market for ubiquitin proteasome research and development was estimated at nearly $2.9 billion in 2013. The market should total more than $5.5 billion by 2018, and have a five-year compound annual growth rate (CAGR) of 14.2% from 2013 to 2018.
Global Markets for Orphan Drugs - Focus on Non-Biologics
With a focus on Non-Biologics, this report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market.
Global Markets for Orphan Drugs - Focus on Biologics
With a focus on Biologics, this report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market.
Global Markets and Technologies for Optical Coherence Tomography ...
This study focuses on full field and optical delay OCT and is a sub report of HLC097A: Global Markets and Technologies for Optical Coherence Tomography (OCT).
Global Markets and Technologies for Optical Coherence Tomography ...
This study focuses on fourier domain and time encoded OCT and is a sub report of HLC097A: Global Markets and Technologies for Optical Coherence Tomography (OCT).
Global Markets and Technologies for Optical Coherence Tomography ...
This study focuses on time domain and polarization sensitive OCT and is a sub report of HLC097A: Global Markets and Technologies for Optical Coherence Tomography (OCT).
Immunoassays: Technologies and Global Markets -- Focus on Infecti...
This study focuses on immunoassays for infectious disease and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.
Immunoassays: Technologies and Global Markets -- Focus on Immunoa...
This study focuses on immunoassays for drug screening and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets
Immunoassays: Technologies and Global Markets -- Focus on Radioim...
This study focuses on radioimmunoassays and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets
Immunoassays: Technologies and Global Markets -- Focus on Diabete...
This study focuses on diabetes laboratory immunoassays and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.
Immunoassays: Technologies and Global Markets -- Focus on Enzyme ...
This study focuses on enzyme immunoassays and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.
Immunoassays: Technologies and Global Markets -- Focus on Fluores...
This study focuses on fluorescent immunoassays and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.
Histone Methyltransferases: Global Markets for Research Tools, Di...
The global market for histone methyltransferases research and development was valued at $93 million in 2012 and is expected to reach $118 million in 2013. The market is further expected to grow at a CAGR of 18.4% and reach $275 million by 2018.
Top Ten Companies in Telemedicine Technologies
The goal of this document is to provide a more in-depth look at the top-tier telemedicine companies as well as some of the second-tier companies to look for in the near future.
Therapies and Biomarkers for Inflammatory Bowel Disease
The market for inflammatory bowel disease therapeutics was valued at $4.8 billion in 2011 and should reach $5 billion in 2012. Total market value is expected to reach nearly $6.2 billion in 2017 after increasing at a five-year compound annual growth rate of 4.1%.
Biologic Imaging Reagents: Technologies and Global Markets
The global market for biologic imaging reagents was valued at $9.4 billion in 2011 and is expected to reach $9.9 billion in 2012. Total market value is expected to reach nearly $14.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 7.8%.
Portable Medical Electronic Products: Technologies and Global Mar...
This study provides a review of the technology used in portable medical electronics products (with a focus on diagnosis and testing), including basic design and fabrication process, and identifies current and emerging applications for this technology.
Emerging Diagnostic Technologies in the Changing U.S. Market
The U.S. emerging diagnostic technologies market was valued at $880 million in 2011 and should reach $1.2 billion in 2012. Total market value is expected to reach $3.2 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 20.9%.
Global Markets for Diabetes Therapeutics and Diagnostics -- Focus...
This report provides detailed market (with a focus on the Americas), technology, and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of diabetes and for devices and instruments used in the diagnosis and monitoring of diabetes. Includes forecasts through 2017.
Global Markets for Diabetes Therapeutics and Diagnostics -- Focus...
This report provides detailed market (with a focus on Asia), technology, and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of diabetes and for devices and instruments used in the diagnosis and monitoring of diabetes. Includes forecasts through 2017.
Nanotechnology in Cancer Treatment: Technologies and Global Markets
This report provides an overview of nanotechnology in cancer treatment and analyzes market trends.
Global Markets and Manufacturing Technologies for Protein Drugs
This report provides an overview of the global markets for protein drugs and drug manufacturing technologies.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
This report provides an overview of the global biochip markets.
Global Microbiome Sequencing Market
This report provides an overview of the global market for microbiome sequencing.